Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China

INTRODUCTION: The objective of the current study was to assess the long-term cost-effectiveness of once-weekly semaglutide 0.5 mg and 1.0 mg versus dulaglutide 1.5 mg for the treatment of patients with type 2 diabetes uncontrolled on metformin in the Chinese setting. METHODS: The Swedish Institute o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Zhen, Ung, Carolina Oi Lam, Shen, Yang, Zhang, Yawen, Wang, Weihao, Luo, Jingyi, Zou, Huimin, Xue, Yan, Wang, Yao, Hu, Hao, Guo, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500126/
https://www.ncbi.nlm.nih.gov/pubmed/35934763
http://dx.doi.org/10.1007/s13300-022-01301-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500126/
https://www.ncbi.nlm.nih.gov/pubmed/35934763
http://dx.doi.org/10.1007/s13300-022-01301-4

Ejemplares similares